The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate

References

• Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancertherapyAdv Drug Deliv Rev200456111649165915350294
   PubMed Web of Science ®Google Scholar
• MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–227128410699287
   PubMed Web of Science ®Google Scholar
• GreishKFangJInutsukaTNagamitsuAMaedaHMacromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targetingClin Pharmacokinet200342131089110514531722
   PubMed Web of Science ®Google Scholar
• RossiJGiassonSKhalidMNDelmasPAllenCLerouxJCLong-circulating poly(ethylene glycol)-coated emulsions to target solid tumorsEur J Pharm Biopharm200767232933817490868
   PubMed Web of Science ®Google Scholar
• GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
   PubMed Web of Science ®Google Scholar
• OwensDE3rdPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
   PubMed Web of Science ®Google Scholar
• ShengYLiuCSYuanYLong-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosanBiomaterials200930122340234819150737
   PubMed Web of Science ®Google Scholar
• StolnikSIllumLDavisSSLong circulating microparticulate drug carriersAdv Drug Deliv Rev1995162–3195214
   Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• WebbMSSaxonDWongFMPComparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristineBiochim Biophys Acta1998137222722829675310
   PubMed Web of Science ®Google Scholar
• SeniorJHFate and behavior of liposomes in vivo: a review of controlling factorsCrit Rev Ther Drug Carrier Syst1987321231933542245
   PubMed Web of Science ®Google Scholar
• AllenTMHansenCMartinFRedemannCYau-YoungALiposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochim Biophys Acta19911066129362065067
   PubMed Web of Science ®Google Scholar
• CharroisGJAllenTMRate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activityBiochim Biophys Acta20031609110210812507764
   PubMed Web of Science ®Google Scholar
• MaruyamaKYudaTOkamotoAIshikuraCKojimaSIwatsuruMEffect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomesChem Pharm Bull (Tokoyo)199139616201622
   PubMed Web of Science ®Google Scholar
• WoodleMCMatthayKKNewmanMSVersatility in lipid composition showing prolonged circulation with sterically stabilized liposomesBiochim Biophys Acta1992110521932001586658
   PubMedGoogle Scholar
• MaruyamaKYudaAOKojimaSSuginakaAIwatsuruMProlonged circulation time in vivo of large unilamellar liposomes composed of distearoylphosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol)Biochim Biophys Acta19921128144491390877
   PubMedGoogle Scholar
• AllenTMHansenCBLopes de MenezesDEPharmacokinetics of long-circulating liposomesAdv Drug Deliv Rev1995161–2267284
   Web of Science ®Google Scholar
• AllenCDos SantosNGallagherRControlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol)Biosci Rep200222222525012428902
   PubMed Web of Science ®Google Scholar
• WangXYIshidaTIchiharaMKiwadaHInfluence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in ratsJ Control Release200510419110215866337
   PubMed Web of Science ®Google Scholar
• ShehataTOgawaraKHigakiKKimuraTProlongation of residence time of liposome by surface-modification with mixture of hydrophilic polymersInt J Pharm20083591–227227918486370
   PubMed Web of Science ®Google Scholar
• Zant-PrzeworskaEStasiukMGubernatorJKozubekAResorcinolic lipids improve the properties of sphingomyelin-cholesterol liposomesChem Phys Lipids2010163764865420561982
   PubMed Web of Science ®Google Scholar
• SihorkarVVyasSPPotential of polysaccharide anchored liposomes in drug delivery, targeting and immunizationJ Pharm Pharm Sci20014213815811466172
   PubMed Web of Science ®Google Scholar
• ZhangJWangSLTopical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effectInt J Pharm20093721–2667519437594
   PubMed Web of Science ®Google Scholar
• EllensEMorseltHWMScherphofGLIn vivo fate of large unilamellar sphingomyelin-cholesterol liposomes after intraperitoneal and intravenous injection into ratsBiochim Biophys Acta1981674110187236723
   PubMedGoogle Scholar
• WebbMSHarasymTOMasinDBallyMBMayerLDSphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour modelsBr J Cancer19957248969047547237
   PubMed Web of Science ®Google Scholar
• SempleSCLeoneRWangJOptimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activityJ Pharm Sci20059451024103815793796
   PubMed Web of Science ®Google Scholar
• FenskeDBWongKFMaurerEIonophore-mediated uptake of ciprofloxacin and vincristine into large unilamellar vesicles exhibiting transmembrane ion gradientsBiochim Biophys Acta199814141–21882049804953
   PubMed Web of Science ®Google Scholar
• SilvermanJADeitcherSRMarqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristineCancer Chemother Pharmacol201371355556423212117
   PubMed Web of Science ®Google Scholar
• DeitcherORGlaspyJGonzalezRHigh-dose vincristine sulfate liposome injection (Marqibo) is not associated with clinically meaningful hematologic toxicityClin Lymphoma Myeloma Leuk201414319720224417913
   PubMed Web of Science ®Google Scholar
• ZhigaltsevIVMaurerNAkhongQFLiposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retentionJ Control Release2005104110311115866338
   PubMed Web of Science ®Google Scholar
• MayerLDNayarRThiesRLBomanNLCullisPRBallyMBIdentification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemiaCancer Chemother Pharmacol199333117248269584
   PubMed Web of Science ®Google Scholar
• ZhangJLiangXLLiXOcular delivery of cyanidin-3-glycoside in liposomes and its prevention of selenite-induced oxidative stressDrug Dev Ind Pharm201642454655326393779
   PubMed Web of Science ®Google Scholar
• ZhangJHanXZLiXCore-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in ratsInt J Nanomedicine201274299431022915851
   PubMed Web of Science ®Google Scholar
• ZolnikBSBurgessDJEvaluation of in vivo-in vitro release of dexamethasone from PLGA microspheresJ Control Release2008127213714518282629
   PubMed Web of Science ®Google Scholar
• KoesterLSOrtegaGGMayorgaPBassaniVLMathematical evaluation of in vitro release profiles of hydroxypropylmethylcellulose matrix tablets containing carbamazepine associated to beta-cyclodextrinEur J Pharm Biopharm200458117717915207552
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration, Center for Drug Evaluation and Research (CDER)Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage FormsRockville, MDFDA1997
   Google Scholar
• LangenbucherFLinearization of dissolution rate curves by the Weibull distributionJ Pharm Pharmacol197224129799814146531
   PubMed Web of Science ®Google Scholar
• GibaldiMFeldmanSEstablishment of sink conditions of dissolution rate determinationsJ Pharm Sci19675610123812426059440
   PubMed Web of Science ®Google Scholar
• WagnerJGInterpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsulesJ Pharm Sci19695810125312575349114
   PubMed Web of Science ®Google Scholar
• ChenJNHeHJLiSSShenQAn HPLC method for the pharmacokinetic study of vincristine sulfate-loaded PLGA–PEG nanoparticle formulations after injection to ratsJ Chromatogr B Analyt Technol Biomed Life Sci20118792119671972
   Web of Science ®Google Scholar
• PregoCTorresDFernandez-MegiaENovoa-CarballalRQuinoaEAlonsoMJChitosan–PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degreeJ Control Release2006111329930816481062
   PubMed Web of Science ®Google Scholar
• ZahrASDavisCAPishkoMVMacrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol)Langmuir200622198178818516952259
   PubMed Web of Science ®Google Scholar
• NakamuraKKamashitaKItohYYoshinoKNozawaSKasukawaHComparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methodsBiochim Biophys Acta20121818112801280722766474
   PubMed Web of Science ®Google Scholar
• ManosroiAPodjanasoonthonKManosroiJStability and release of topical tranexamic acid liposome formulationsJ Cosmet Sci200253637538612512014
   PubMed Web of Science ®Google Scholar
• CostaPSousa LoboJMModeling and comparison of dissolution profilesEur J Pharm Sci200113212313311297896
   PubMed Web of Science ®Google Scholar
• DesaiSJSinghPSimonelliAPHiguchiWIInvestigation of factors influencing release of solid drug dispersed in inert matrices. II. Quantitation of proceduresJ Pharm Sci19965511122412295969776
   PubMedGoogle Scholar
• BomanNLCullisPRMayerLDBallyMBWebbMSLiposomal vincristine: the central role of drug retention in defining therapeutically optimized anticancer formulationsWoodleMCStormGLong Circulating Liposomes: Old Drugs, New TherapeuticsGeorgetown, TXLandes Bioscience19972949
   Google Scholar
• ChonnASempleSCCullisPRAssociation of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimesJ Biol Chem19922672618759187651527006
   PubMed Web of Science ®Google Scholar
• WoodleMCCollinsLRSponslerEKossovskyNPapahadjopoulosDMartinFJSterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potentialBiophys J19926149029101581503
   PubMed Web of Science ®Google Scholar
• OtsukaHNagasakiYKataokaKPEGylated nanoparticles for biological and pharmaceutical applicationsAdv Drug Deliv Rev200355340341912628324
   PubMed Web of Science ®Google Scholar
• VonarbourgAPassiraniCSaulnierPBenoitJPParameters influencing the stealthiness of colloidal drug delivery systemsBiomaterials200627244356437316650890
   PubMed Web of Science ®Google Scholar
• HuYJiangXDingYPreparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly (ethylene oxide)-polylactide amphiphilic copolymer nanoparticlesBiomaterials200324132395240412699677
   PubMed Web of Science ®Google Scholar
• ParveenSSahooSKLong circulating chitosan/PEG blended PLGA nanoparticle for tumor drug deliveryEur J Pharmacol20116702–337238321951969
   PubMed Web of Science ®Google Scholar
• ParveenSMitraMKrishnakumarSSahooSKEnhanced antiproliferative activity of carboplatin-loaded chitosan-alginate nanoparticles in a retinoblastoma cell lineActa Biomater2010683120313120149903
   PubMed Web of Science ®Google Scholar
• MoghimiSMSzebeniJStealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesProg Lipid Res200342646347814559067
   PubMed Web of Science ®Google Scholar
• RigottiAActonSLKriegerMThe class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipidsJ Biol Chem19952702716221162247541795
   PubMed Web of Science ®Google Scholar